Cerebrolysin vs Piracetam for memory
Short answer: For memory, more users report improvement with Cerebrolysin — 96% of 24 reports, versus 87% of 113 for Piracetam.
Cerebrolysin has 30 meta-analyses and 60 randomized trials on PubMed; Piracetam has 119 and 117.
Based on 196 reports about Cerebrolysin and 789 about Piracetam. Not medical advice.
| Cerebrolysin Peptide | Piracetam Supplement | |
|---|---|---|
| User score | 49 | 50 |
| Verdict | Mostly positive | Mixed |
| Positive of reports that state an outcome | 75% | 52% |
| Reports | 196 | 789 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 30 / 60 | 119 / 117 |
| Mainly used for | ||
| Focus % reporting improvement | 90% (21) | 74% (248) |
| Energy % reporting improvement | 88% (8) | 85% (46) |
| Sleep % reporting improvement | 100% (5) | 44% (9) |
| Anxiety % reporting improvement | 89% (9) | 86% (42) |
| Mood % reporting improvement | 90% (20) | 79% (71) |
| Memory % reporting improvement | 96% (24) | 87% (113) |
| Performance % reporting improvement | — | 100% (2) |
| Recovery % reporting improvement | 100% (3) | — |
| Pain & inflammation % reporting improvement | 100% (2) | 100% (4) |
| Libido % reporting improvement | — | 20% (5) |
| Heart & lipids % reporting improvement | — | 80% (5) |
| Immunity % reporting improvement | — | 67% (3) |
| Common side effects | brain fog, fatigue, headache, tingling | brain fog, headache, fatigue, irritability |
| Typical dose reported | Not listed | daily |
Ginkgo biloba extracts have shown the greatest cognitive and functional benefits, though their clinical significance remains uncertain, and certainty of evidence is overall low. Future trials should focus on a single VCI subtype, prioritize interventions with a strong mechanistic rationale, standardize diagnostic criteria, ensure adequate power for chosen outcomes, test against placebo, and implement FAIR data sharing to accelerate therapeutic discovery.
Alzheimers Dement, 2025 ↗“Cerebrolysin is by far the best nootropic I have ever used...my memory, recall ability, sensitivity to music, observance over my emotions, thinking faculties have all improved to a noticeable amount.”
High-level evidence related to pharmacological strategies for managing Lewy body dementia is rare. Strategies for important areas of need in Lewy body dementia, such as autonomic symptoms and caregiver burden, have not been investigated, nor have the views of patients and caregivers about pharmacological strategies.
Am J Psychiatry, 2015 ↗“The effects were wonderful, they still are to me-- verbal fluidity, increased motivation, quicker thinking, better recall, pro social, wake up in the morning with ZERO grogginess.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate